Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Tandem duplication PCR: an ultrasensitive assay for the detection of internal tandem duplications of the FLT3 gene.

Lin MT, Tseng LH, Beierl K, Hsieh A, Thiess M, Chase N, Stafford A, Levis MJ, Eshleman JR, Gocke CD.

Diagn Mol Pathol. 2013 Sep;22(3):149-55. doi: 10.1097/PDM.0b013e31828308a1.

2.

A Novel Tandem Duplication Assay to Detect Minimal Residual Disease in FLT3/ITD AML.

Lin MT, Tseng LH, Dudley JC, Riel S, Tsai H, Zheng G, Pratz KW, Levis MJ, Gocke CD.

Mol Diagn Ther. 2015 Dec;19(6):409-17. doi: 10.1007/s40291-015-0170-3.

3.

Detection of minor clones with internal tandem duplication mutations of FLT3 gene in acute myeloid leukemia using delta-PCR.

Beierl K, Tseng LH, Beierl R, Haley L, Gocke CD, Eshleman JR, Lin MT.

Diagn Mol Pathol. 2013 Mar;22(1):1-9. doi: 10.1097/PDM.0b013e31825d81f4.

PMID:
23370424
4.

Improved FLT3 internal tandem duplication PCR assay predicts outcome after allogeneic transplant for acute myeloid leukemia.

Grunwald MR, Tseng LH, Lin MT, Pratz KW, Eshleman JR, Levis MJ, Gocke CD.

Biol Blood Marrow Transplant. 2014 Dec;20(12):1989-95. doi: 10.1016/j.bbmt.2014.08.015. Epub 2014 Aug 23.

5.

Medium-sized FLT3 internal tandem duplications confer worse prognosis than short and long duplications in a non-elderly acute myeloid leukemia cohort.

Koszarska M, Meggyesi N, Bors A, Batai A, Csacsovszki O, Lehoczky E, Adam E, Kozma A, Lovas N, Sipos A, Krahling T, Dolgos J, Remenyi P, Fekete S, Masszi T, Tordai A, Andrikovics H.

Leuk Lymphoma. 2014 Jul;55(7):1510-7. doi: 10.3109/10428194.2013.850163. Epub 2013 Nov 25.

PMID:
24090502
6.

Identification of emerging FLT3 ITD-positive clones during clinical remission and kinetics of disease relapse in acute myeloid leukaemia with mutated nucleophosmin.

Ottone T, Zaza S, Divona M, Hasan SK, Lavorgna S, Laterza S, Cicconi L, Panetta P, Di Giandomenico J, Cittadini M, Ciardi C, Montefusco E, Franchi A, Annino L, Venditti A, Amadori S, Lo-Coco F.

Br J Haematol. 2013 May;161(4):533-40. doi: 10.1111/bjh.12288. Epub 2013 Mar 11.

PMID:
23480665
7.

[Prevalence and clinical significance of FLT3 internal tandem duplication mutation in acute leukemia].

Wang LH, Zhou CL, Zhang XW, Chen S, Wang M, Wang JX.

Zhonghua Xue Ye Xue Za Zhi. 2004 Jul;25(7):393-6. Chinese.

PMID:
15355689
8.

Detection of FLT3 internal tandem duplication in targeted, short-read-length, next-generation sequencing data.

Spencer DH, Abel HJ, Lockwood CM, Payton JE, Szankasi P, Kelley TW, Kulkarni S, Pfeifer JD, Duncavage EJ.

J Mol Diagn. 2013 Jan;15(1):81-93. doi: 10.1016/j.jmoldx.2012.08.001. Epub 2012 Nov 14.

9.

[Correlation of FLT3 gene expression level and internal tandem duplication mutation in acute myeloid leukemia and its clinical significance].

Wang YG, Liu XH, Liang Y, Jin J.

Zhonghua Xue Ye Xue Za Zhi. 2008 Nov;29(11):741-5. Chinese.

PMID:
19176010
10.

[Clinical significance of FLT3 internal tandem duplication in acute myeloid leukemia with chromosome abnormality].

Wang J, Li S, Wang T.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Aug;15(4):700-4. Chinese.

PMID:
17708786
11.

Prognostic significance and detection of the internal tandem duplication of the FLT3 gene in acute myeloid leukemia.

Gagyi E, Horváth E, Bödör C, Timár B, Matolcsy A, Pávai Z.

Rom J Morphol Embryol. 2006;47(4):331-7.

12.

Single cell analysis exposes intratumor heterogeneity and suggests that FLT3-ITD is a late event in leukemogenesis.

Shouval R, Shlush LI, Yehudai-Resheff S, Ali S, Pery N, Shapiro E, Tzukerman M, Rowe JM, Zuckerman T.

Exp Hematol. 2014 Jun;42(6):457-63. doi: 10.1016/j.exphem.2014.01.010. Epub 2014 Feb 2.

PMID:
24495871
13.

Influence of FLT3-internal tandem duplication allele burden and white blood cell count on the outcome in patients with intermediate-risk karyotype acute myeloid leukemia.

How J, Sykes J, Gupta V, Yee KW, Schimmer AD, Schuh AC, Minden MD, Kamel-Reid S, Brandwein JM.

Cancer. 2012 Dec 15;118(24):6110-7. doi: 10.1002/cncr.27683. Epub 2012 Jun 26.

14.

Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia.

Shamaa S, Laimon N, Aladle DA, Azmy E, Elghannam DM, Salem DA, Taalab MM.

Hematology. 2014 Jan;19(1):22-30. doi: 10.1179/1607845413Y.0000000085. Epub 2013 Nov 25.

PMID:
23540998
15.

Patient-specific analysis of FLT3 internal tandem duplications for the prognostication and monitoring of acute myeloid leukemia.

Schiller J, Praulich I, Krings Rocha C, Kreuzer KA.

Eur J Haematol. 2012 Jul;89(1):53-62. doi: 10.1111/j.1600-0609.2012.01785.x. Epub 2012 May 9.

PMID:
22458420
16.

[FMS-like tyrosine kinase 3 gene mutations in acute myeloid leukemia].

Han YL, Zhang SJ, Qiao C, Dai D, Sun XM, Xu YL, Qian SX, Xu W, Wang JS, Li JY.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Oct;17(5):1135-9. Chinese.

PMID:
19840437
17.

[Expression of FLT3 internal tandem duplication in pediatric patients with acute myeloid leukemia and its correlation with multidrug resistance].

Zhao JN, Qiao ZH, Xu LR, Lu QY, Niu XQ, Zhang P, Wang Z.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Feb;17(1):23-6. Chinese.

PMID:
19236740
18.

Internal tandem duplication and Asp835 mutations of the FMS-like tyrosine kinase 3 (FLT3) gene in acute promyelocytic leukemia.

Shih LY, Kuo MC, Liang DC, Huang CF, Lin TL, Wu JH, Wang PN, Dunn P, Lai CL.

Cancer. 2003 Sep 15;98(6):1206-16.

19.

[Simultaneous detection of FLT3-ITD and NPM1 gene mutations in acute myeloid leukemia by double PCR].

Zhang ZC, Lu QY, Zhao JN, Chen YM, Li ZP.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Jun;19(3):717-20. Chinese.

PMID:
21729557
20.

Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemia.

Abdelhamid E, Preudhomme C, Helevaut N, Nibourel O, Gardin C, Rousselot P, Castaigne S, Gruson B, Berthon C, Soua Z, Renneville A.

Leuk Res. 2012 Mar;36(3):316-23. doi: 10.1016/j.leukres.2011.11.002. Epub 2011 Nov 29.

PMID:
22129478

Supplemental Content

Support Center